Scientific Programme

Update 26 April 2020

Due to the latest COVID-19 developments, the EPA Board has decided to transform the 28th European Congress of Psychiatry in Madrid into a fully virtual meeting taking place 4 – 7 July 2020.

Click here for more information.

Please note that the EPA is doing its best to ensure that the virtual meeting will incorporate as much of the congress experience and activities as possible. All individuals involved will be contacted and ongoing updates on programme schedule will be announced in due course.


*The programme is regularly updated with new confirmed sessions and speakers. Please note that the programme is subject to change.

Click on the session titles for detailed information. Session descriptions are available below.

Plenary Lectures

The Digital Future of Mental Health: Achievements and Scenarios

  • Speaker: Prof. Dror Ben-Zeev

Psychopathology 2020: The Heritage of Karl Jaspers

  • Speaker: Prof. Mario Maj

The Stepchild of Medicine: Psychiatry’s Notorious Past and Bright Future

  • Speaker: Prof. Jeffrey Lieberman

State of the Art Lectures

Eating Disorders: From Neurobiological Factors Involved to Therapy

  • Speaker: Prof. Janet Treasure

Precision Medicine in Psychiatry: A Roadmap for Future Research and Care

  • Speaker: Prof. Celso Arango

Behavioural Addictions (Gambling, Internet, Food, Sex, Exercise...): Where Does It Start, Where Does It End?

  • Speaker: Prof. Anneke Goudriaan

Specialised Services for First Episode Psychosis: Which Psychopharmacology, Which Psychotherapy and Beyond

  • Speaker: Prof. Christoph Correll

Bipolar Disorder: Keys to Successful Outcomes

  • Speaker: Prof. Eduard Vieta

Regaining Control in Drug Addiction: (How) Does It Work?

  • Speaker: Prof. Falk Kiefer


Antidepressants in Bipolar Depression: Should We Use Them?

  • Pro: Dr. Isabella Pacchiarotti
  • Con: Prof. Guy Goodwin

Do We Need Antipsychotics for The Long-Term Treatment of Schizophrenia?

  • Pro: Prof. Robin Emsley
  • Con: Dr. Joanna Moncrieff

Is Psychotherapy the First Line of Treatment for Borderline Personality Disorder?

  • Pro: Prof. Laurence Claes
  • Con: TBA

Core Symposia

Person-Centred Research and Care for People with Schizophrenia

  • Lecture Titles:
    • The Perspective of Hospital-Based Care
      • Speaker: Prof. Wolfgang Gaebel
    • The Perspective of Community-Based Care
      • Speaker: Prof. Michaela Amering
    • Integrated Treatment for People with Schizophrenia
      • Speaker: Prof. Armida Mucci
    • Digital-Based Platform for Early Detection and Intervention
      • Speaker: Nikolaos Koutsouleris

Deep Brain Stimulation for Our Patients: When, How and Where?

  • Lecture Titles:
    • OCD
      • Speaker: Prof. Luc Mallet
    • MDD
      • Speaker: TBA
    • Addiction
      • Speaker: Jens Kuhn
    • Anorexia Nervosa
      • Speaker: Dr. Victor Perez Sola

Examples of How a Dimensional Approach in Mood Disorders is Useful in Clinical Practice

  • Lecture Titles:
    • Activation in Bipolar Disorder
      • Speaker: Prof. Jan Scott
    • Motivation and Energy in Bipolar Disorder
      • Speaker: Dr. Kathleen Merikangas
    • Sleep, Personalised Treatment, Depression
      • Speaker: Dr. Pierre Alexis Geoffroy
    • Emotional Reactivity in Bipolar Disorder
      • Speaker: Prof. Chantal Henry

Monotherapy Against Polypharmacy in Schizophrenia: What is the Evidence?

  • Lecture Titles:
    • Risks and Benefits of Antipsychotic Polypharmacy vs Monotherapy in Schizophrenia
      • Speaker: Prof. Christoph Correll
    • Are There Specific Antipsychotic Combinations That Are Superior to Monotherapies in The Long-Term Treatment of Schizophrenia?
      • Speaker: Prof. Jari Tiihonen
    • Evaluation of Safety Data on Antipsychotic Polypharmacy
      • Speaker: Prof. Andrea Cipriani
    • Complex Evaluation of The Efficiency of Antipsychotic Monotherapy Versus Polypharmacy in Schizophrenia With The Help of A Nationwide Database
      • Speaker: Prof. Istvan Bitter

Building the Future of Evidence-Based Medicine: RCT and Beyond

  • Lecture Titles:
    • Neuromodulation
      • Speaker: Prof. Chris Baeken
    • Psychotherapy and E-Mental Health
      • Speaker: Prof. Pim Cuijpers
    • Child Psychiatry
      • Speaker: Prof. Bruno Falissard
    • Pharmacology
      • Speaker: Prof. Wolfgang Fleischhacker

Personalised Psychiatry and its Impact on Treatment and Outcome in Eating Disorders

  • Lecture Titles:
    • Does Neurocognitive Function Predict Therapy Outcome in ED
      • Speaker: Prof. Kate Tchanturia
    • When Does it Stop? Defining Remission and Recovery in Eating Disorders
      • Speaker: Prof. Philip Gorwood
    • ED Psychopathology Challenged by Network Analysis
      • Speaker: Dr. Alessio Monteleone
    • Predictors of the Impact of Pychotherapeutic Approaches in Anorexia Nervosa
      • Speaker: Prof. Stephan Zipfel

The European Congress of Psychiatry serves the educational mission of the EPA by providing high-quality EPA Courses, covering all aspects of psychiatry. Fees are charged separately for the courses. Each EPA Course is composed of two 90-minute sessions.


The State-of-the-Art lectures have a strong clinical focus, providing a complete update on significant aspects of current clinical treatments in European psychiatry. The State-of-the-Art lectures are delivered by top European or worldwide experts and last 45 minutes.


The Plenary lectures are mainly theoretical and research-oriented, with a strong scientific focus. These lectures are delivered by leading psychiatrists, scientists and other mental health professionals invited by the Scientific Programme Committee. They cover the major topics of the Congress theme.


Debates offer a lively and fruitful discussion on controversial issues. A chairperson moderates the debate and the following discussion, while two speakers (proponent /opponent) offer and challenge opinions on “hot topics” for 30 minutes each. Participants may also be asked to interact by voting at the beginning and/or end of the session.


These 90-minute sessions, selected by the Scientific Programme Committee, focus on specific topics in psychiatry, representing several points of view. Each symposium includes four presentations by international speakers and offers an opportunity for discussion at the end.

State of the art

The Workshops are devoted to a specific topic and bring together experts in this field for an intensive discussion. These are 90-minute working sessions, with 30 minutes devoted to discussion and interactivity.


The EPA invites recent graduates to follow its specialist programme, which is tailored to the needs and interests of early career psychiatrists. The ECP Programme is composed of a Networking Evening and a special track of sessions throughout the Congress.


Ask the Experts sessions allow participants to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new perspectives. Sessions take place at round tables and are limited to a certain number of participants with advanced sign-up required.


The EPA Forums brings together EPA Council of National Psychiatric Association (NPA) members and individual EPA members, along with other European organisations, stakeholders and policy makers, to present and discuss matters of European importance in the field of Mental Health and Mental Health Care.


Authors are invited to submit abstracts, classified by topics. There is a limitation concerning the number of submissions per individual. Submitted abstracts are reviewed by the Scientific Programme Committee and scheduled as Oral Communications Sessions, e-Poster Presentations, or e-Poster Viewing.
Those abstracts scoring the highest will be allotted an Oral Communication Session in which the author will have 8-10 minutes to present the research in the presence of colleagues with related research.


Authors in the second-highest category of scoring are invited to present their research findings or important ongoing research as an e-Poster Presentation, where they have 2-3 minutes to present their e-Posters (in front of the e-Poster station) in the presence of a chairperson and colleagues with related research.


All other authors accepted for e-Poster status will be able to view their poster at one of 15-17 e-Poster stations located around the congress centre. The stations are accessible to all delegates throughout the Congress for individual viewing. All accepted posters whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.


Satellite Symposia are organised by pharmaceutical companies in consultation with the Scientific Programme Committee. These sessions are fully integrated into the Congress, but are sessions entirely designed, produced and driven by the pharmaceutical industries by an unrestricted educational grant.